Stock Ticker

  • Loading stock data...

Boston Scientific Corporation (NYSE:BSX) Brings BP Lowering Device

Boston, MA 10/29/2013 (wallstreetpr) – Boston Scientific Corporation (NYSE:BSX) has good news for hypertension or high blood pressure patients. Its new equipment called – Vessix- will now allow doctors to treat hypertension patients, who no longer respond to medical treatment. The procedure using Vessix will allow doctors to now lower blood pressure to normal measurements. Such […]

Boston Scientific Corporation (NYSE:BSX) To Cut 1500 Jobs Even With Narrower Quarterly Losses

Boston, MA 10/25/2013 (wallstreetpr) – It seems that the mistake of 2005 will continue to haunt Boston Scientific Corporation (NYSE:BSX) forever. The company’s profit and loss accounts have bled for last 8 years since the time company decided to purchase heart implant maker Guidant for an eye-popping $27 billion. And that was the last time company […]

Unending Court Cases For Boston Scientific Corporation (NYSE:BSX)

Boston, MA 10/23/2013 (wallstreetpr) – Over the last three months, Boston Scientific Corporation (NYSE:BSX) has traded an average of 15 million shares a day. However on Monday October 21, the company traded just 9 million shares but managed to set a 52 week high of $12.48 and has a low of $5.04. This is a 3.45% gain […]

Boston Scientific Corporation (NYSE:BSX) Scrip Reads Hold

Boston, MA 10/17/2013 (wallstreetpr) – Boston Scientific Corporation (NYSE:BSX), much like other medical device manufacturers, has seen dwindling sales and contracting revenues for quite some time now. The medical devices market has for along time now remained weak owing to a number of constraints in the industry. Amid these challenges, analysts have recently reviewed the […]

Boston Scientific Corporation (NYSE:BSX)’s Shares Surge Ahead of Quarterly Results

Boston, MA 10/15/2013 (wallstreetpr) – Boston Scientific Corporation (NYSE:BSX) has been trading in green ahead of its third quarter earnings to be declared on October 24’2013. It has been a view that the company is engaged in a revival attempt which could be reflected in its second quarter results as well. The company which is a […]

Boston Scientific Corporation (NYSE:BSX) Shows Revival Efforts

Boston, MA 10/14/2013 (wallstreetpr) –  After several quarters of lackluster performance, Boston Scientific Corporation (NYSE:BSX) has begun showing encouraging revival efforts. This is well captured in its Q2.13 results. In the earnings for the most recent quarter, BSX posted $0.18 in EPS, smashing the consensus %0.16 and climbing over $0.17 EPS in the comparable quarter a […]

Sunshine Heart (NASDAQ:SSH) Device Receives Approval From FDA- SSH, ABMD, BSX, SPNC, EW

Sunshine Heart Inc (NASDAQ:SSH) announced on Tuesday that it got unconditional authorization from the Food and Drug Administration to start its pivotal U.S. trial for its flagship C-Pulse Heart Assist System. Shares climbed 17 percent premarket to $7.74. As of Monday’s close, the stock was dropped 4.5 percent over the previous three months. Accordant to […]

Cyberonics (NASDAQ:CYBX) Cheers on Satisfy Quarter Profit – CYBX, BSX, MDT, STJ, HOLX

Medical device maker Cyberonics, Inc. (NASDAQ:CYBX)’s shares jumped around 13% on Friday following the firm declared fiscal Q2 earnings, increased by a one-time gain, in front of estimates. Cyberonics generated 44 cents per share, increased 37 percent from the year-earlier quarter. Analysts had anticipated a profit of 39 cents per share. With Friday’s gain, shares […]

MRI Interventions Drops More than 23% After Yesterday’s High (MRIC)

MRI Interventions (OTC: MRIC) saw its first huge drop today since the company went public with its stock offering on May 21, 2012. The company’s stock price had been steadily rising since it dropped from $1.09 to $0.75 on June 19, 2012.  It reached its highest close yesterday, at $4.45. It opened at $4.56 this morning, and the price […]